Adam S. Mostafa

CIK: 0001738081

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (40.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

XFOR

X4 Pharmaceuticals, Inc

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

XFOR
X4 Pharmaceuticals, Inc
Feb 12, 2025
Award(A)
Direct
850K shares-
XFOR
X4 Pharmaceuticals, Inc
Jan 24, 2025
Sale(S)
Direct
74.8K shares at avg. $0.45$34K
XFOR
X4 Pharmaceuticals, Inc
Jan 23, 2025
Award(A)
Direct
74.8K shares-
XFOR
X4 Pharmaceuticals, Inc
Oct 7, 2024
Sale(S)
Direct
230.6K shares at avg. $0.55$127K
XFOR
X4 Pharmaceuticals, Inc
Oct 4, 2024
Award(A)
Direct
230.6K shares-

		Type	Shares	Price		Ownership
Feb 12, 2025	XFOR X4 Pharmaceuticals, Inc	Award(A)	850,000	-	-	Direct
Jan 24, 2025	XFOR X4 Pharmaceuticals, Inc	Sale(S)	74,773	$0.45	$33,947	Direct
Jan 23, 2025	XFOR X4 Pharmaceuticals, Inc	Award(A)	74,773	-	$0	Direct
Oct 7, 2024	XFOR X4 Pharmaceuticals, Inc	Sale(S)	230,645	$0.55	$126,901	Direct
Oct 4, 2024	XFOR X4 Pharmaceuticals, Inc	Award(A)	230,645	-	$0	Direct

1-5 of 5 transactions

About Mostafa Adam S.

Mostafa Adam S. (SEC CIK 0001738081) files insider reports with the SEC as Chief Financial Officer of X4 Pharmaceuticals, Inc (XFOR).

Signal8 holds 3 ownership filings by Mostafa Adam S., all Form 4s, filed between Oct 8, 2024 and Feb 14, 2025. Those filings report 5 transactions, from Oct 4, 2024 to Feb 12, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Mostafa Adam S.'s filings is in BOSTON, MA.

Recent filings by Mostafa Adam S.

Feb 12, 2025: Grant or award of XFOR shares (Form 4, code A).
Jan 24, 2025: Open-market sale of XFOR shares (Form 4, code S).
Jan 23, 2025: Grant or award of XFOR shares (Form 4, code A).
Oct 7, 2024: Open-market sale of XFOR shares (Form 4, code S).
Oct 4, 2024: Grant or award of XFOR shares (Form 4, code A).

Other insiders filing for X4 Pharmaceuticals, Inc (XFOR)

Craig Adam R, Executive Chairman
KIRSKE DAVID, Chief Financial Officer
Volpone John, President
Gold Kelly, Director
Bridger Gary, Director
de Craecker Francoise, Director

How to read Form 4 transaction codes